EcoR1 Capital’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,223,851
| Closed | -$51.5M | – | 59 |
|
|
2024
Q3 | $51.5M | Sell |
3,223,851
-2,490,553
| -44% | -$39.8M | 1.76% | 15 |
|
|
2024
Q2 | $51.6M | Buy |
5,714,404
+95,625
| +2% | +$863K | 1.58% | 17 |
|
|
2024
Q1 | $63.5M | Hold |
5,618,779
| – | – | 1.61% | 20 |
|
|
2023
Q4 | $44.7M | Hold |
5,618,779
| – | – | 1.16% | 17 |
|
|
2023
Q3 | $36.4M | Hold |
5,618,779
| – | – | 1.23% | 16 |
|
|
2023
Q2 | $34.8M | Hold |
5,618,779
| – | – | 0.85% | 18 |
|
|
2023
Q1 | $21.6M | Buy |
5,618,779
+386,500
| +7% | +$1.49M | 0.7% | 24 |
|
|
2022
Q4 | $16.2M | Buy |
5,232,279
+1,995,927
| +62% | +$6.19M | 0.49% | 32 |
|
|
2022
Q3 | $13M | Buy |
3,236,352
+2,944,032
| +1,007% | +$11.8M | 0.38% | 35 |
|
|
2022
Q2 | $1.42M | Sell |
292,320
-162,225
| -36% | -$790K | 0.05% | 65 |
|
|
2022
Q1 | $4.08M | Sell |
454,545
-427,631
| -48% | -$3.84M | 0.13% | 55 |
|
|
2021
Q4 | $9.93M | Buy |
882,176
+127,631
| +17% | +$1.44M | 0.32% | 37 |
|
|
2021
Q3 | $12.6M | Hold |
754,545
| – | – | 0.44% | 29 |
|
|
2021
Q2 | $16.8M | Buy |
+754,545
| New | +$16.8M | 0.63% | 30 |
|